Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty: a Randomized Controlled Trial

NCT06740214 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06740214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06740214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty: a Randomized Controlled Trial
Lead sponsor
The University of Hong Kong
Phase
Phase 3
Overall status
Recruiting
Start date
September 4, 2025
Completion date
June 30, 2028
Enrollment
177 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesic effect, dose response relationship, drug, liposomal bupivacaine, pain, postoperative, total knee arthroplasty